MedPath

CONCERTA 36 mg COMPRIMIDOS DE LIBERACION PROLONGADA

CONCERTA 36 mg COMPRIMIDOS DE LIBERACION PROLONGADA

Commercialized
Register Number

65170

Prescription Type

Medicamento Sujeto A Prescripción Médica. Psicótropos

Authorization Date

Jan 22, 2003

Dosage Form

COMPRIMIDO DE LIBERACIÓN PROLONGADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number65170
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

METILFENIDATOActive
Quantity: 36 mg
Name: METILFENIDATO

ATC CLASSIFICATION (2)

N06B
N06BA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.